E139 – SGLT2 inhibitors for kidney and heart disease
Release Date:
Normally used as a glucose-lowering agent in the treatment of type 2 diabetes, SGLT2 inhibitors have been found to have beneficial effects in patients with heart failure and kidney disease. Jo Cheah finds out more from cardiologist John Atherton.
E139 – SGLT2 inhibitors for kidney and heart disease